Digestive Diseases and Sciences

Papers
(The H4-Index of Digestive Diseases and Sciences is 22. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-10-01 to 2025-10-01.)
ArticleCitations
Acknowledgment of 2021 Reviewers50
Is Evidence of Absence Considered Absence of Evidence? How Negative Studies Inform Shared Decision-Making44
Serendipity Strikes: How Pursuing Novel Hypotheses Shifted the Paradigm Regarding the Genetic Basis of Colorectal Cancer and Changed Cancer Therapy41
Trainee Involvement and ERCP Complications: A Systematic Review and Meta-Analysis36
Fecal Microbiota Transplantation (FMT) and Clinical Outcomes Among Inflammatory Bowel Disease (IBD) Patients: An Umbrella Review35
Retraction Note: Silencing of Long Noncoding RNA SNHG6 Inhibits Esophageal Squamous Cell Carcinoma Progression via miR-186-5p/HIF1α Axis35
Esophageal Perforation Secondary to 4-Day Impaction of a Large Fish Bone33
Effectiveness and Safety of Lumen-Apposing Metal Stents in Endoscopic Interventions for Off-Label Indications32
Physical Activity and Risk of Hepatocellular Carcinoma: A Systematic Review and Meta-Analysis32
Bi-directional Relationship Between Celiac Disease and Liver Chemistries: A Systematic Review and Meta-Analysis31
Impact of High-Flow Nasal Cannula Oxygenation on the Prevention of Hypoxia During Endoscopic Retrograde Cholangiopancreatography in Elderly Patients: A Randomized Clinical Trial29
Azathioprine with Allopurinol Is a Promising First-Line Therapy for Inflammatory Bowel Diseases28
Endoscopy in End-Stage Renal Disease: Timing Matters28
Correlations Between Gastrointestinal Symptoms and Endoscopic–Histologic Disease Activity in Adults with Ulcerative Colitis28
Emerging Frontiers in Colorectal Cancer Therapy: From Targeted Molecules to Immunomodulatory Breakthroughs and Cell-Based Approaches28
Everything that You Always Wanted to Know About the Management of Percutaneous Endoscopic Gastrostomy (PEG) Tubes (but Were Afraid to Ask)27
Methodological Issues to Be Considered in Evaluating Advanced Endoscopic Resection Techniques in Cirrhosis26
Caution When Interpreting Endoscopic Sleeve Gastroplasty Outcomes from Surgery-Based Databases25
Baseline Severity and Inflammation Would Influence the Effect of Simvastatin on Clinical Outcomes in Cirrhosis Patients25
TET2 Is Downregulated in Early Esophageal Squamous Cell Carcinoma and Promotes Esophageal Squamous Cell Malignant Behaviors25
Managing Intestinal Failure – Success of a 12-STEPS Program24
Progression of Crohn’s Disease in Newly Diagnosed Patients: Results from an Observational Study Using US Claims Data22
Eosinophilic Esophagitis: Lessons Learned from Its Evolution22
Proinflammatory Effects of Wheat and Rye in an IBD Model: Give Us Not Our Daily Bread22
0.24195408821106